Ignite Creation Date:
2024-05-06 @ 10:43 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03337724
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2017-11-07
Brief Title:
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CAAKT1PTEN-Altered Locally Advanced or Metastatic Triple-Negative Breast Cancer or Hormone Receptor-Positive HER2-Negative Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-04
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-07
First Submit QC Date:
November 7 2017
Study First Post Date:
2017-11-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-03-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-15
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL